Rifampin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rifampin Injection (injection) from Sanofi-Aventis U.S. LLC with status Current. The shortage was first posted on Feb 17, 2021. Reported reason: Discontinuation of the manufacture of the drug
Shortage details
- Status
- Current
- Company
- Sanofi-Aventis U.S. LLC
- Package NDC
- 0068-0597-01
- Dosage Form
- Injection
- Presentation
- Rifadin, Injection, 600 mg (NDC 0068-0597-01)
- Initial Posting
- Feb 17, 2021
Reason
Discontinuation of the manufacture of the drug